Jens Lundgren

Researcher Next ID · RN-021284

Researcher · Medicine

University of Copenhagen

Copenhagen, Denmark

Not currently recruitingFunding unknown

Works count: 1,108
Citation count: 60,859
H-index: 109
i10-index: 628

Research interests

Medicine

Immunology and Microbiology

HIV/AIDS drug development and treatment

HIV-related health complications and treatments

HIV/AIDS Research and Interventions

HIV Research and Treatment

Pneumocystis jirovecii pneumonia detection and treatment

Publications

Remdesivir for the Treatment of Covid-19 — Final Report
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2007764
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)30418-0
Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study
The Lancet HIV · 2018 · https://doi.org/10.1016/s2352-3018(18)30043-2
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.
Clinical Infectious Diseases · 2016 · https://doi.org/10.1093/cid/ciw668
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
JAMA · 2016 · https://doi.org/10.1001/jama.2016.5148
Profound Endothelial Damage Predicts Impending Organ Failure and Death in Sepsis
Seminars in Thrombosis and Hemostasis · 2015 · https://doi.org/10.1055/s-0034-1398377
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study
European Journal of Preventive Cardiology · 2015 · https://doi.org/10.1177/2047487315579291
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
The Lancet Global Health · 2013 · https://doi.org/10.1016/s2214-109x(13)70172-4
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
The Journal of Infectious Diseases · 2009 · https://doi.org/10.1086/649897
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
PLoS Medicine · 2008 · https://doi.org/10.1371/journal.pmed.0050203
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies
The Lancet · 2003 · https://doi.org/10.1016/s0140-6736(03)14229-8
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
The Lancet · 2002 · https://doi.org/10.1016/s0140-6736(02)09411-4
Changing patterns of mortality across Europe in patients infected with HIV-1
The Lancet · 1998 · https://doi.org/10.1016/s0140-6736(98)03201-2

Current projects

No projects listed.